Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL)

Filed by TARPLIN, DOWNS & YOUNG, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
4th Quarter - Report
Posted
Jan 20, 2026
Income
$80,000.00
Expenses
Not reported
Filing UUID
30dfc9f7-bc74-4966-bb82-fbfeeab44a37
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

H.R. 4121 / S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304 / S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 5371 Continuing Appropriations and Extensions Act of 2026

Literal federal measure citations: H.R. 4121, S. 2256, H.R. 5304, S. 2587, H.R. 5371

HCR · Health Issues

S. 2211 - A bill to reauthorize the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians H.R. 5461 - the Special Diabetes Program Reauthorization Act of 2025 H.R. 5488 - To amend title III of the Public Health Service Act to extend funding for the Special Diabetes Program for Indians Issues pertaining to NIH research Issues pertaining to cell and gene therapies Issues pertaining to c-peptide Issues pertaining to the United States Preventive Services Taskforce

Literal federal measure citations: S. 2211, H.R. 5461, H.R. 5488

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.